These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5846873)

  • 21. [Case reports of digestive diseases caused by auto-antibodies].
    Oliver-Pascual E; Sanz Esponera J; Fernandez Basave E; Puras E
    Rev Esp Enferm Apar Dig; 1965; 24(6):721-31. PubMed ID: 5846874
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of anti-tissue antibodies in the evolution of chronic liver diseases].
    Buligescu L; Moscaliuc I; Eşanu I; Ionică M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(6):445-52. PubMed ID: 6121363
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic liver diseases with autoimmunity].
    Lopez-Calderon Barreda
    Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):563-8. PubMed ID: 5363140
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interpretation, applications, and limitations of autoantibodies in chronic autoimmune hepatitis].
    Díaz Jouanen E
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S63-4. PubMed ID: 8948785
    [No Abstract]   [Full Text] [Related]  

  • 25. [Symposium on clinical aspects and pathogenesis of autoimmune diseases. (7). Studies on immunological injury of the liver].
    Yamamoto S
    Nihon Naika Gakkai Zasshi; 1967 Dec; 56(12):1395-6. PubMed ID: 5627233
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of various indices of T and B immunity systems in patients with chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1983 Aug; (8):94-8. PubMed ID: 6605624
    [No Abstract]   [Full Text] [Related]  

  • 27. [HB virus antigens in the liver during chronic hepatitis in children].
    Alvarez F; Bernard O; Alagille D
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():767-70. PubMed ID: 6762178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic reactions in chronic liver disease].
    Bondar' ZA; Finogenova LG; Zolotnitskaia RP
    Ter Arkh; 1971 Aug; 43(8):26-30. PubMed ID: 5151772
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dysglobulinemic and atypical cirrhosis. Immunological aspects].
    Varay A; Hartmann L; Ollier MP; Drain JD
    Rev Int Hepatol; 1967 May; 17(6):621-34. PubMed ID: 4172856
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis.
    Fusconi M; Vannini A; Dall'Aglio AC; Pappas G; Cassani F; Ballardini G; Frisoni M; Grassi A; Bianchi FB; Zauli D
    Aliment Pharmacol Ther; 2005 Nov; 22(10):951-5. PubMed ID: 16268969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihepatic antibodies in cirrhosis of the liver and chronic hepatitis in children].
    Ziabkina AG; Chistova LV; Fokina TV; Markov KhM
    Pediatriia; 1971 May; 50(5):45-7. PubMed ID: 5122491
    [No Abstract]   [Full Text] [Related]  

  • 32. LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity.
    Csepregi A; Nemesánszky E; Luettig B; Obermayer-Straub P; Manns MP
    Am J Gastroenterol; 2001 Mar; 96(3):910-1. PubMed ID: 11280576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of circulating immune complexes in chronic hepatopathies].
    Delsignore R; Baroni MC; Mineo F; Conversi E; Campana G; Butturini U
    G Clin Med; 1984; 65(9-10):389-94. PubMed ID: 6530118
    [No Abstract]   [Full Text] [Related]  

  • 34. Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    Acta Biochim Pol; 1995; 42(2):197-200. PubMed ID: 8588463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the possible role of autoimmunization in liver cirrhosis.
    Mori W
    Bull Tokyo Med Dent Univ; 1965 Jun; 12(2):185-97. PubMed ID: 4157520
    [No Abstract]   [Full Text] [Related]  

  • 36. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease.
    Loria P; Carulli N; Lonardo A
    Am J Gastroenterol; 2005 May; 100(5):1200-1; author reply 1201-2. PubMed ID: 15842599
    [No Abstract]   [Full Text] [Related]  

  • 37. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigations on the immunological mechanism in chronic hepatitis and postviral hepatic cirrhosis].
    Fodor O; Părău N; Nicoară G; Ban A
    Stud Cercet Med Interna; 1965; 6(4):371-7. PubMed ID: 5865722
    [No Abstract]   [Full Text] [Related]  

  • 39. The validity and importance of subtypes in autoimmune hepatitis: a point of view.
    Czaja AJ; Manns MP
    Am J Gastroenterol; 1995 Aug; 90(8):1206-11. PubMed ID: 7639216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The positive rate of auto antibodies and autoimmune liver diseases in patients with abnormal liver function].
    Liu YM; Yan HP; Wang JT
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):360-2. PubMed ID: 15225434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.